Altre lingue Sinco Pharmaceuticals Holdings Limited

Azioni

6833

KYG8154Y1052

Mercato chiuso - Hong Kong S.E. Altri mercati azionari 10:08:15 18/04/2024			Variaz. 5gg	Var. 1 gen.
0,25 ^HKD	0,00%		+2,46%	+4,17%

26/03	Sinco Pharmaceuticals Holdings Limited riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
26/03	Sinco Pharmaceuticals Holdings Limited Dimissioni di Li Kin Wai come Segretario aziendale congiunto e nomina di Peng Yunlu come Direttore esecutivo	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Sinco Pharmaceuticals' 2023 Profit Declines on Higher Tax Payments	27/03
Sinco Pharmaceuticals Holdings Limited Proposes Final Cash Dividend for the Year Ended 31 December 2023, Payable on 04 June 2024	26/03
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Sinco Pharmaceuticals Holdings Limited Resignation of Li Kin Wai as Joint Company Secretary and Appointment of Peng Yunlu as Executive Director	26/03
Sinco Pharmaceuticals Warns of Lower 2023 Profit	13/03
Sinco Pharmaceuticals Holdings Limited Provides Consolidated Earning Guidance for the Year Ended 31 December 2023	13/03
Sinco Pharmaceuticals Holdings Limited(SEHK:6833) dropped from S&P Global BMI Index	18/09/23
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
Sinco Pharmaceuticals Warns of 68% Drop in H1 Profit	16/08/23
Sinco Pharmaceuticals Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023	16/08/23
Sinco Pharma Taps Moore Advisory Services for Internal Control Review	01/05/23
Sinco Pharmaceuticals Co-CEO Resigns; Shares Slip 3%	30/03/23
Sinco Pharmaceuticals Holdings Limited Announces Final Dividend for the Year Ended 31 December 2022, Payable on June 15, 2023	29/03/23
Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	29/03/23
Sinco Pharmaceuticals Holdings Limited Announces Chief Executive Officer Changes	29/03/23
Sinco Pharmaceuticals Holdings Limited Appoints Lei Shifeng as Executive Director, with Effect from 29 March 2023	29/03/23
Sinco Pharmaceuticals Expects 50% Drop in 2022 Profit; Shares Slip 4%	16/03/23
Sinco Pharmaceuticals Holdings Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022	15/03/23
Sinco Pharmaceuticals Holdings Limited completed the acquisition of Deyang Demei Medical Aesthetic Clinic from Jiang Biao, Jiang Min and Jiang Jun.	31/12/22
Sinco Pharmaceuticals Searching for New Auditor Following EY's Resignation	08/12/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Sinco Pharmaceuticals Holdings Limited

Azioni

6833

KYG8154Y1052

Altre lingue

Filtri